Invasion as limitation to anti-angiogenic glioma therapy.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Acta neurochirurgica. Supplement

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-7091-6090-9_23PMID 14531575
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells

  2004cited by this paper
• The vascular response to tumor infiltration in malignant gliomas

  2004cited by this paper
• Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1.

  2003cited by this paper
• Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A.

  2003cited by this paper
• Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.

  2002cited by this paper
• Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma

  2002cited by this paper
• Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.

  2002cited by this paper
• World Health Organization Classification of Tumours

  2002cited by this paper
• Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy

  2001cited by this paper
• Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1).

  2001cited by this paper
• Heterogeneous vascular dependence of tumor cell populations.

  2001cited by this paper
• Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2.

  2001cited by this paper
• Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

  2001cited by this paper
• Vascular Apoptosis and Involution in Gliomas Precede Neovascularization: A Novel Concept for Glioma Growth and Angiogenesis

  2000cited by this paper
• Hypoxia-Induced Tumour Cell Migration in an in vivo Chicken Model

  2000cited by this paper
• Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption.

  2000cited by this paper
• Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

  1999cited by this paper
• Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.

  1999cited by this paper
• Hypoxia‐mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression

  1999cited by this paper
• Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy.

  1999cited by this paper
• Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis

  1999cited by this paper
• Implantation of C6 astrocytoma spheroid into collagen type I gels: invasive, proliferative, and enzymatic characterizations.

  1997cited by this paper
• Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis.

  1997cited by this paper
• Halting angiogenesis suppresses carcinoma cell invasion

  1997cited by this paper
• Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.

  1996cited by this paper
• Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors.

  1995cited by this paper
• Glioblastoma Cells Do Not Intravasate into Blood Vessels: 124

  1995cited by this paper
• Molecular Mechanisms of Developmental and Tumor Angiogenesis

  1994cited by this paper
• Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

  1994cited by this paper
• Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections.

  1994cited by this paper
• Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

  1993cited by this paper
• Tumours acquire their vasculature by vessel incorporation, not vessel ingrowth

  1987cited by this paper
• Tumor angiogenesis: a quantitative method for histologic grading.

  1972cited by this paper
• Transplacental carcinogenesis by stilbestrol.

  1971cited by this paper
• Tumor angiogenesis: therapeutic implications.

  1971cited by this paper
• THE FORMS OF GROWTH IN GLIOMAS AND THEIR PRACTICAL SIGNIFICANCE

  1940cited by this paper

• Discovery of the MELK–Nucleostemin Axis in Glioblastoma: Implications for p53 Regulation and Tumor Progression

  2026cites this paper
• Selected aspects of avascular tumor growth reproduced by a hybrid model of cell dynamics and chemical kinetics.

  2024cites this paper
• An agonistic anti-Tie2 antibody suppresses the normal-to-tumor vascular transition in the glioblastoma invasion zone

  2023cites this paper
• Contrast enhancing pattern on pre-treatment MRI predicts response to anti-angiogenic treatment in recurrent glioblastoma: comparison of bevacizumab and temozolomide treatment

  2022cites this paper
• Evaluation of anti-angiogenic agent F16 for targeting glioblastoma xenograft tumors.

  2022cites this paper
• Drug delivery and targeting to brain tumors: considerations for crossing the blood-brain barrier

  2021cites this paper
• Relapse pattern and quality of life in patients with localized basal ganglia germinoma receiving focal radiotherapy, whole-brain radiotherapy, or craniospinal irradiation.

  2021cites this paper
• Application of a simple device for “attracting” and “trapping” glioma cells in situ

  2021cites this paper
• A phenotype-structured model to reproduce the avascular growth of a tumor and its interaction with the surrounding environment.

  2021cites this paper
• Multicellular Ovarian Cancer Model for Evaluation of Nanovector Delivery in Ascites and Metastatic Environments

  2021cites this paper
• Vascular co‐option and vasculogenic mimicry mediate resistance to antiangiogenic strategies

  2020cites this paper
• Ultra-Low Dose Amiodarone Reduces Tumor Growth and Angiogenesis

  2020cites this paper
• Amalgamation of PI3K and EZH2 blockade synergistically regulates invasion and angiogenesis: combination therapy for glioblastoma multiforme

  2020cites this paper
• Understanding the glioblastoma tumor biology to optimize photodynamic therapy: From molecular to cellular events

  2020cites this paper
• Apelin Controls Angiogenesis-Dependent Glioblastoma Growth

  2020cites this paper
• Pleiotropic Chemotherapy to Abrogate Glioblastoma Multiforme Migration/Invasion

  2019cites this paper
• The landscape of postsurgical recurrence patterns in diffuse low-grade gliomas.

  2019cites this paper
• Mathematical modeling of tumor-associated macrophage interactions with the cancer microenvironment

  2018cites this paper
• Sulforaphane from Cruciferous Vegetables: Recent Advances to Improve Glioblastoma Treatment

  2018cites this paper
• AG488 as a therapy against gliomas

  2017cites this paper
• Vascular regulation of glioma stem-like cells: a balancing act.

  2017cites this paper
• Apelin and Cancer

  2017cites this paper
• Examining the effects of macrophage populations on cancerous tumor growth.

  2017cites this paper
• Nanoscale upconversion for oxygen sensing.

  2017cites this paper
• Carboxyethylpyrroles: From Hypothesis to the Discovery of Biologically Active Natural Products.

  2017cites this paper
• Bevacizumab combined with chemotherapy for glioblastoma: a meta-analysis of randomized controlled trials

  2017cites this paper
• Caffeine suppresses the progression of human glioblastoma via cathepsin B and MAPK signaling pathway.

  2016cites this paper
• EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells

  2016cites this paper
• Fibulin-5 inhibits the cell proliferation , migration and angiogenesis in glioma

  2016cites this paper
• EphrinB 2 drives perivascular invasion and proliferation of glioblastoma stem-like cells

  2016cites this paper
• Drug Repurposing to Circumvent Chemotherapy Resistance in Brain Tumours

  2016cites this paper
• Anti-cancer Properties and Relevant Mechanisms of Cordycepin, an Active Ingredient of the Insect Fungus Cordyceps spp.,

  2015cites this paper
• Mathematical Modeling of Branching Morphogenesis and Vascular Tumor Growth

  2015cites this paper
• Improved Treatment Efficacy of Antiangiogenic Therapy when Combined with Picornavirus Vaccination in the GL261 Glioma Model

  2015cites this paper
• Magnetic Resonance for non-invasive evaluation of preclinical models of human brain tumors

  2015cites this paper
• Diffuse gliomas: exploiting molecular and metabolic characteristics for improved diagnosis and therapy

  2015cites this paper
• Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?

  2015cites this paper
• Second-Line Chemotherapy in Recurrent Glioblastoma: A 2-Cohort Study

  2015cites this paper
• Bridging the Gap Between Modeling of Tumor Growth and Clinical Imaging

  2014cites this paper
• Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression

  2014cites this paper
• A Multilayer Grow-or-Go Model for GBM: Effects of Invasive Cells and Anti-Angiogenesis on Growth

  2014influential citation
• Bevacizumab in high-grade gliomas: a review of its uses, toxicity assessment, and future treatment challenges

  2013cites this paper
• Mechanisms of Tumor Development and Anti-angiogenic Therapy in Glioblastoma Multiforme

  2013cites this paper
• Identifying new small molecule anti-invasive compounds for glioma treatment

  2013cites this paper
• Release of tissue inhibitor of metalloproteinase-2 from alginate microcapsule encapsulating genetically engineered cells

  2013cites this paper
• Inhibition of AGS human gastric cancer cell invasion and proliferation by Capsosiphon fulvescens glycoprotein

  2013cites this paper
• Effects of Dual Targeting of Tumor Cells and Stroma in Human Glioblastoma Xenografts with a Tyrosine Kinase Inhibitor against c-MET and VEGFR2

  2013cites this paper
• Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.

  2013cites this paper
• Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach

  2013cites this paper
• Expression of the Arp2/3 complex in human gliomas and its role in the migration and invasion of glioma cells.

  2013cites this paper
• Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma.

  2013cites this paper
• Controlling tumor invasion: bevacizumab and BMP4 for glioblastoma.

  2013cites this paper
• VEGF in tumor progression and targeted therapy.

  2013cites this paper
• Neutrophil activation induces peripheral immunosuppression in glioblastoma and stroke

  2013cites this paper
• Balancing risks and benefits of anti-angiogenic drugs for malignant glioma

  2013cites this paper
• Is Gliomatosis Cerebri a Diffuse Low-Grade Glioma?

  2013cites this paper
• Nouveaux marqueurs des glioblastomes : valeur pronostique, profil d’expression, implication dans la vascularisation et la résistance aux antiangiogéniques

  2013cites this paper
• Multivoxel ¹H MR spectroscopy is superior to contrast-enhanced MRI for response assessment after anti-angiogenic treatment of orthotopic human glioma xenografts and provides handles for metabolic targeting.

  2013cites this paper
• Diffusion-weighted MRI as a biomarker for treatment response in glioma.

  2012cites this paper
• Endoscopy-verified occult subependymal dissemination of glioblastoma and brain metastasis undetected by MRI: prognostic significance

  2012cites this paper
• Current concepts in brain tumor imaging.

  2012cites this paper
• Angiogenesis and invasion in cancer.

  2012cites this paper
• Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion.

  2012cites this paper
• Protein kinases in high grade glioma: Towards therapeutic concoctions

  2012cites this paper
• Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions

  2012cites this paper
• Diffusion-weighted MRI as a biomarker for treatment response in glioma Review

  2012cites this paper
• Calpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment

  2012cites this paper
• Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma

  2012cites this paper
• A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma.

  2011cites this paper
• Glial Brain Tumors: Antiangiogenic Therapy

  2011cites this paper
• Synergistic Effects of Arsenic Trioxide and Silibinin on Apoptosis and Invasion in Human Glioblastoma U87MG Cell Line

  2011cites this paper
• Glioma cell migration on three-dimensional nanofiber scaffolds is regulated by substrate topography and abolished by inhibition of STAT3 signaling.

  2011cites this paper
• Bevacizumab antiangiogenic therapy for glioblastoma

  2011cites this paper
• Angiogenesis and invasion in glioma

  2011cites this paper
• Nervous System: Glioma: an overview

  2011cites this paper
• Effector T-Cell Infiltration Positively Impacts Survival of Glioblastoma Patients and Is Impaired by Tumor-Derived TGF-β

  2011cites this paper
• 6 Discrete cell modeling 1 With

  2011cites this paper
• Glioblastoma: Current Chemotherapeutic Status and Need for New Targets and Approaches

  2011cites this paper
• Phase II study of sunitinib malate in patients with recurrent high-grade glioma

  2011cites this paper
• Exciting New Advances in Neuro‐Oncology: The Avenue to a Cure for Malignant Glioma

  2010cites this paper
• Malignant gliomas: new translational therapies.

  2010cites this paper
• Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies.

  2010cites this paper
• Standard Treatment Options for High-grade Glioma Surgery for High-grade Glioma

  2010cites this paper
• Use of Thymidine Kinase Gene-Modified Endothelial Progenitor Cells as a Vector Targeting Angiogenesis in Glioma Gene Therapy

  2010cites this paper
• Dual inhibition of sodium-mediated proton and calcium efflux triggers non-apoptotic cell death in malignant gliomas.

  2010cites this paper
• Bevacizumab Monotherapy for Temozolomide-Refractory Malignant Glioma

  2010cites this paper
• Could Be Systems-Directed Therapy Approaches Promising in Glioblastoma Patients?

  2010cites this paper
• Immunhistochemische Analyse des axonalen Lenkungsfaktors Netrin-1 und seines Rezeptors DCC (deleted in colorectal cancer) in humanen Gliomen

  2010influential citation
• Inositol-requiring enzyme 1α is a key regulator of angiogenesis and invasion in malignant glioma

  2010cites this paper
• Detection of failure of bevacizumab treatment for malignant glioma based on urinary matrix metalloproteinase activity

  2010cites this paper
• Three-dimensional multispecies nonlinear tumor growth-II: Tumor invasion and angiogenesis.

  2010cites this paper
• Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice

  2010cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2010cites this paper
• Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab.

  2009cites this paper
• Therapeutic strategies for inhibiting invasion in glioblastoma

  2009cites this paper
• Antiangiogenic therapies for high-grade glioma

  2009cites this paper
• Angiogenesis inhibition in high grade glioma Verhoeff

  2009cites this paper
• Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation.

  2009cites this paper
• Multiparameter computational modeling of tumor invasion.

  2009cites this paper
• Interference RNA Intervention in Brain Tumors

  2009cites this paper